- Home
- TCX vs TNXP Comparison
TCX vs TNXP Comparison
Compare TCX & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCX
- TNXP
- Stock Information
- Founded
- TCX 1992
- TNXP 2007
- Country
- TCX Canada
- TNXP United States
- Employees
- TCX 765
- TNXP N/A
- Industry
- TCX EDP Services
- TNXP Biotechnology: Pharmaceutical Preparations
- Sector
- TCX Technology
- TNXP Health Care
- Exchange
- TCX Nasdaq
- TNXP Nasdaq
- Market Cap
- TCX 220.5M
- TNXP 207.5M
- IPO Year
- TCX 1996
- TNXP N/A
- Fundamental
- Price
- TCX $19.76
- TNXP $33.33
- Analyst Decision
- TCX
- TNXP Strong Buy
- Analyst Count
- TCX 0
- TNXP 2
- Target Price
- TCX N/A
- TNXP $585.00
- AVG Volume (30 Days)
- TCX 16.4K
- TNXP 1.1M
- Earning Date
- TCX 08-07-2025
- TNXP 08-15-2025
- Dividend Yield
- TCX N/A
- TNXP N/A
- EPS Growth
- TCX N/A
- TNXP N/A
- EPS
- TCX N/A
- TNXP N/A
- Revenue
- TCX $369,427,000.00
- TNXP $10,041,000.00
- Revenue This Year
- TCX N/A
- TNXP $11.66
- Revenue Next Year
- TCX N/A
- TNXP $793.18
- P/E Ratio
- TCX N/A
- TNXP N/A
- Revenue Growth
- TCX 6.66
- TNXP N/A
- 52 Week Low
- TCX $13.27
- TNXP $6.76
- 52 Week High
- TCX $26.48
- TNXP $137.25
- Technical
- Relative Strength Index (RSI)
- TCX 56.57
- TNXP 52.50
- Support Level
- TCX $19.54
- TNXP $33.41
- Resistance Level
- TCX $21.69
- TNXP $37.42
- Average True Range (ATR)
- TCX 0.74
- TNXP 3.48
- MACD
- TCX -0.07
- TNXP -1.12
- Stochastic Oscillator
- TCX 28.78
- TNXP 33.66
About TCX Tucows Inc.
Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains. Geographically company operates in USA, Canada and Europe.
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.